[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100611528":3},{"organization":4,"armGroups":7,"interventions":7,"overallOfficials":7,"centralContacts":8,"locations":7,"responsibleParty":14,"collaborators":7,"id":18,"slug":19,"hasResults":20,"nctId":21,"briefTitle":22,"officialTitle":23,"acronym":7,"eligibilityCriteria":24,"healthyVolunteers":20,"sex":25,"minAge":26,"maxAge":27,"enrollmentInfo":28,"targetDuration":7,"studyType":31,"phases":7,"briefSummary":32,"conditions":33,"keywords":7,"overallStatus":37,"whyStopped":7,"lastUpdateSubmitDate":38,"lastUpdatePostDateStruct":39,"startDateStruct":42,"completionDateStruct":44,"leadSponsor":46,"locationsCount":7},{"fullName":5,"class":6},"Assiut University","OTHER",null,[9],{"name":10,"role":11,"phone":12,"phoneExt":7,"email":13},"Dalia Abdelrahim Fakhry, Principal Investigator","CONTACT","+201126915064","Dalia.17289777@med.aun.edu.eg",{"type":15,"investigatorFullName":16,"investigatorTitle":17,"investigatorAffiliation":5,"oldNameTitle":7,"oldOrganization":7},"PRINCIPAL_INVESTIGATOR","Dalia Abdelrahim Fakhry Hussein","Principal Investigator","100611528","predictors-of-drug-resistant-epilepsy-among-pediatric-patients-100611528",false,"NCT07241754","Predictors of Drug Resistant Epilepsy Among Pediatric Patients","Predictors of Anti-seizure Medication Resistance in Pediatric Epilepsy","Inclusion Criteria:\n\n* Children aged 1-18 years with a confirmed diagnosis of epilepsy.\n* Both males and females will be included.\n\nExclusion Criteria:\n\n* Children younger than 1 year or older than 18 years.\n* Patients with acute symptomatic seizures (e.g., febrile seizures, metabolic or infectious causes) or pseudo refractory epilepsy (e .g. syncope or uncorrect ASMs)\n* Patients controlled on antiseizure medications\n* Refusal of parents or guardians to participate in the study","ALL","1 Year","18 Years",{"count":29,"type":30},200,"ESTIMATED","OBSERVATIONAL","1. This study aims to determine the main predictors of drug resistance in pediatric epilepsy by examining clinical data, EEG abnormalities, and neuroimaging results, in order to support early identification of resistant cases and improve treatment strategies .\n2. Early introduction of new lines of treatment in case of refractory epilepsy as : Ketogenic diet , Rituximab and solumedrol",[34,35,36],"Epilepsy","Seizure","Resistance","NOT_YET_RECRUITING","2025-12-09",{"date":40,"type":41},"2025-12-17","ACTUAL",{"date":43,"type":30},"2025-12-29",{"date":45,"type":30},"2027-02-01",{"name":5,"class":6}]